Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 927-935

  Norata, Giuseppe Danilo ^a,b   Venu, Vivek Krishna Pulakazhi ^a   Callegari, Elisa ^a   Paloschi, Valentina ^a   Catapano, Alberico Luigi ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale Bassini   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

Atherosclerosis; BNDF; Vascular disorder

Indexed keywords

ANGIOPOIETIN RECEPTOR; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; CRE RECOMBINASE; FIBRILLAR COLLAGEN; LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BODY WEIGHT; CONTROLLED STUDY; DNA MICROARRAY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; LIPID BLOOD LEVEL; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; INTEGRASES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKB; SEQUENCE DELETION;

ANIMALIA; MUS;

EID: 84859090258     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.02.014     Document Type: Article

References (32)

1. Kraemer R., Baker P.J., Kent K.C., Ye Y., Han J.J., Tejada R., Silane M., Upmacis R., Deeb R., Chen Y., Levine D.M., Hempstead B. Decreased neurotrophin TrkB receptor expression reduces lesion size in the apolipoprotein E-null mutant mouse. Circulation 2005, 112:3644-3653.
2. Donovan M.J., Miranda R.C., Kraemer R., McCaffrey T.A., Tessarollo L., Mahadeo D., Sharif S., Kaplan D.R., Tsoulfas P., Parada L., et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am. J. Pathol. 1995, 147:309-324.
3. Ejiri J., Inoue N., Kobayashi S., Shiraki R., Otsui K., Honjo T., Takahashi M., Ohashi Y., Ichikawa S., Terashima M., Mori T., Awano K., Shinke T., Shite J., Hirata K., Yokozaki H., Kawashima S., Yokoyama M. Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 2005, 112:2114-2120.
4. Lommatzsch M., Virchow J.C. Letter regarding article by Ejiri et al, "Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease". Circulation 2006, 113:e724. author reply e724-725.
5. Manni L., Nikolova V., Vyagova D., Chaldakov G.N., Aloe L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int. J. Cardiol. 2005, 102:169-171.
6. Donovan M.J., Lin M.I., Wiegn P., Ringstedt T., Kraemer R., Hahn R., Wang S., Ibanez C.F., Rafii S., Hempstead B.L. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000, 127:4531-4540.
7. Wagner N., Wagner K.D., Theres H., Englert C., Schedl A., Scholz H. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Genes Dev. 2005, 19:2631-2642.
8. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., Sun B., Tandon N.N. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb. Haemost. 2002, 87:728-734.
9. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N., Sun B. Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 2000, 470:113-117.
10. Kermani P., Hempstead B. Brain-derived neurotrophic factor: a newly described mediator of angiogenesis. Trends Cardiovasc. Med. 2007, 17:140-143.
11. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 1999, 189:865-870.
12. Constien R., Forde A., Liliensiek B., Grone H.J., Nawroth P., Hammerling G., Arnold B. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line. Genesis 2001, 30:36-44.
13. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 2001, 230:230-242.
14. de Lange F.J., Moorman A.F., Anderson R.H., Manner J., Soufan A.T., de Gier-de Vries C., Schneider M.D., Webb S., van den Hoff M.J., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 2004, 95:645-654.
15. Norata G.D., Marchesi P., Passamonti S., Pirillo A., Violi F., Catapano A.L. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007, 191:265-271.
16. Norata G.D., Callegari E., Marchesi M., Chiesa G., Eriksson P., Catapano A.L. High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells. Circulation 2005, 111:2805-2811.
17. Norata G.D., Marchesi P., Pulakazhi Venu V.K., Pasqualini F., Anselmo A., Moalli F., Pizzitola I., Garlanda C., Mantovani A., Catapano A.L. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 2009, 120:699-708.
18. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball C.A., Causton H.C., Gaasterland T., Glenisson P., Holstege F.C., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29:365-371.
19. Norata G.D., Callegari E., Inoue H., Catapano A.L. HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler. Thromb. Vasc. Biol. 2004, 24:871-877.
20. Norata G.D., Tibolla G., Seccomandi P.M., Poletti A., Catapano A.L. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J. Clin. Endocrinol. Metab. 2006, 91:546-554.
21. Radka S.F., Holst P.A., Fritsche M., Altar C.A. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res. 1996, 709:122-301.
22. Conforti P., Ramos C., Apostol B.L., Simmons D.A., Nguyen H.P., Riess O., Thompson L.M., Zuccato C., Cattaneo E. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347. Mol. Cell. Neurosci. 2008, 39:1-7.
23. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
24. Veillard N.R., Steffens S., Burger F., Pelli G., Mach F. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2339-2344.
25. Newby A.C., Zaltsman A.B. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 1999, 41:345-360.
26. Kermani P., Rafii D., Jin D.K., Whitlock P., Schaffer W., Chiang A., Vincent L., Friedrich M., Shido K., Hackett N.R., Crystal R.G., Rafii S., Hempstead B.L. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J. Clin. Invest. 2005, 115:653-663.
27. Schecterson L.C., Bothwell M. Neurotrophin receptors: old friends with new partners. Dev Neurobiol 2010, 70:332-338.
28. Hara Y., Nomura T., Yoshizaki K., Frisen J., Osumi N. Impaired hippocampal neurogenesis and vascular formation in ephrin-A5-deficient mice. Stem Cells 2010, 28:974-983.
29. Yancey P.G., Blakemore J., Ding L., Fan D., Overton C.D., Zhang Y., Linton M.F., Fazio S. Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler Thromb Vasc Biol 2010, 30:787-795.
30. Massa S.M., Yang T., Xie Y., Shi J., Bilgen M., Joyce J.N., Nehama D., Rajadas J., Longo F.M. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 2010, 120:1774-1785.
31. Santhanam A.V., Smith L.A., Katusic Z.S. Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 2010, 41:350-356.
32. Liu Y., Sun L., Huan Y., Zhao H., Deng J. Application of bFGF and BDNF to improve angiogenesis and cardiac function. J. Surg. Res. 2006, 136:85-91.